FdaApplication
ANDA 211537
Identifiers
- fda_app_no: ANDA211537
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2026-04-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE | DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE | 10MG;EQ 5MG BASE | TABLET;ORAL |
1 product